Skip to main content
Erschienen in:

01.12.2022 | Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors)

Pediatric Overactive Bladder and the Role of Sacral Neuromodulation

verfasst von: Ashley W. Johnston, MD, Benjamin M. Whittam, MD, MS

Erschienen in: Current Treatment Options in Pediatrics | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Overactive bladder is the most common cause of voiding dysfunction in the pediatric population. Bladder overactivity can be challenging to address often requiring “trial and error” and a multimodal treatment plan. The purpose of this manuscript is to summarize the role and efficacy of sacral neuromodulation in the treatment of pediatric bladder overactivity.

Recent Findings

The exact mechanism of action of sacral neuromodulation is poorly understood. Sacral neuromodulation likely has a multifactorial effect on the voiding pathway acting on both the peripheral and central nervous system per functional MRI studies. Modulation of a child’s developing neural pathways has shown to have durable effects with improvements persisting after the device has been deactivated and/or explanted.

Summary

Pediatric bladder overactivity should be treated in step-wise fashion, starting with the least invasive therapy. Sacral neuromodulation should be considered only in refractory cases. Sacral neuromodulation is effective in decreasing, and may completely resolve bothersome lower urinary tract symptoms. These improvements in bladder symptoms translate into improvements in a child’s and caregiver’s quality of life. In appropriately selected patients, sacral neuromodulation is a succesful long-term treatment for overactive bladder.
Literatur
2.
Zurück zum Zitat Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35:471–81 John Wiley & Sons.CrossRef Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35:471–81 John Wiley & Sons.CrossRef
3.
Zurück zum Zitat Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, Brubaker L, Van Den Eeden SK, et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. 2006;175:989–93 Wolters KluwerPhiladelphia, PA.CrossRef Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, Brubaker L, Van Den Eeden SK, et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. 2006;175:989–93 Wolters KluwerPhiladelphia, PA.CrossRef
4.
Zurück zum Zitat Natale N, Kuhn S, Siemer S, Stöckle M, von Gontard A. Quality of life and self-esteem for children with urinary urge incontinence and voiding postponement. J Urol. 2009;182:692–8.CrossRef Natale N, Kuhn S, Siemer S, Stöckle M, von Gontard A. Quality of life and self-esteem for children with urinary urge incontinence and voiding postponement. J Urol. 2009;182:692–8.CrossRef
5.
Zurück zum Zitat van den Heijkant M, Bogaert G. Lower urinary tract terminology in daytime lower urinary tract symptoms in children: a view of the pediatric urologist. Eur Urol Focus. 2017;3:189–97 Elsevier.CrossRef van den Heijkant M, Bogaert G. Lower urinary tract terminology in daytime lower urinary tract symptoms in children: a view of the pediatric urologist. Eur Urol Focus. 2017;3:189–97 Elsevier.CrossRef
6.
Zurück zum Zitat Nieuwhof-Leppink AJ, Hussong J, Chase J, Larsson J, Renson C, Hoebeke P, et al. Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children’s Continence Society (ICCS). J Pediatr Urol. 2021;17:172–81 Elsevier.CrossRef Nieuwhof-Leppink AJ, Hussong J, Chase J, Larsson J, Renson C, Hoebeke P, et al. Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children’s Continence Society (ICCS). J Pediatr Urol. 2021;17:172–81 Elsevier.CrossRef
7.
Zurück zum Zitat Meijer EFJ, Nieuwhof-Leppink AJ, Dekker-Vasse E, De Joode-Smink GCJ, De Jong TPVM. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program. J Pediatr Urol J Pediatr Urol. 2015;11:21.e1-21.e5.CrossRef Meijer EFJ, Nieuwhof-Leppink AJ, Dekker-Vasse E, De Joode-Smink GCJ, De Jong TPVM. Central inhibition of refractory overactive bladder complaints, results of an inpatient training program. J Pediatr Urol J Pediatr Urol. 2015;11:21.e1-21.e5.CrossRef
8.
Zurück zum Zitat Vijverberg MAW, Elzinga-Plomp A, Messer AP, Van Gool JD, De Jong TPVM. Bladder rehabilitation, the effect of a cognitive training programme on urge incontinence. Eur Urol Eur Urol. 1997;31:68–72.CrossRef Vijverberg MAW, Elzinga-Plomp A, Messer AP, Van Gool JD, De Jong TPVM. Bladder rehabilitation, the effect of a cognitive training programme on urge incontinence. Eur Urol Eur Urol. 1997;31:68–72.CrossRef
10.
Zurück zum Zitat Franco I. Overactive bladder in children. Part 2: management. J Urol. 2007;178:769–74.CrossRef Franco I. Overactive bladder in children. Part 2: management. J Urol. 2007;178:769–74.CrossRef
12.
Zurück zum Zitat Blais AS, Nadeau G, Moore K, Genois L, Bolduc S. Prospective pilot study of mirabegron in pediatric patients with overactive bladder. Eur Urol. 2016;70:9–13 Elsevier.CrossRef Blais AS, Nadeau G, Moore K, Genois L, Bolduc S. Prospective pilot study of mirabegron in pediatric patients with overactive bladder. Eur Urol. 2016;70:9–13 Elsevier.CrossRef
13.
Zurück zum Zitat Arlen AM. Dysfunctional voiders—medication versus urotherapy? Current urology reports. Current Medicine Group LLC. 2017;1(18):1–6. Arlen AM. Dysfunctional voiders—medication versus urotherapy? Current urology reports. Current Medicine Group LLC. 2017;1(18):1–6.
14.
Zurück zum Zitat Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, et al. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176:328–31 United States.CrossRef Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, et al. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176:328–31 United States.CrossRef
15.
Zurück zum Zitat Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989;142:340–5 United States.CrossRef Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989;142:340–5 United States.CrossRef
16.
Zurück zum Zitat Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–6 Wolters KluwerPhiladelphia, PA.CrossRef Guys JM, Haddad M, Planche D, Torre M, Louis-Borrione C, Breaud J. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–6 Wolters KluwerPhiladelphia, PA.CrossRef
17.
Zurück zum Zitat Humphreys MR, Vandersteen DR, Slezak JM, Hollatz P, Smith CA, Smith JE, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176:2227–31 No longer published by Elsevier.CrossRef Humphreys MR, Vandersteen DR, Slezak JM, Hollatz P, Smith CA, Smith JE, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176:2227–31 No longer published by Elsevier.CrossRef
18.
Zurück zum Zitat Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, Brink TS, Marks BK, Quirouet A, et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198:1379–85.CrossRef Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, Brink TS, Marks BK, Quirouet A, et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198:1379–85.CrossRef
19.
Zurück zum Zitat Fowler CJ, van Kerrebroeck PE, Nordenbo A, Van Poppel H. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (sexual and urological disorders in multiple sclerosis). J Neurol Neurosurg Psychiatry. 1992;55:986–9.CrossRef Fowler CJ, van Kerrebroeck PE, Nordenbo A, Van Poppel H. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (sexual and urological disorders in multiple sclerosis). J Neurol Neurosurg Psychiatry. 1992;55:986–9.CrossRef
20.
Zurück zum Zitat Boswell TC, Hollatz P, Hutcheson JC, Vandersteen DR, Reinberg YE. Device outcomes in pediatric sacral neuromodulation: a single center series of 187 patients. J Pediatr Urol. 2021;17:72.e1-72.e7 Elsevier.CrossRef Boswell TC, Hollatz P, Hutcheson JC, Vandersteen DR, Reinberg YE. Device outcomes in pediatric sacral neuromodulation: a single center series of 187 patients. J Pediatr Urol. 2021;17:72.e1-72.e7 Elsevier.CrossRef
21.
Zurück zum Zitat Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008;180:306–11.CrossRef Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008;180:306–11.CrossRef
22.
Zurück zum Zitat Groen L-A, Hoebeke P, Loret N, Van Praet C, Van Laecke E, Ann R, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–7 2012/08/16. United States.CrossRef Groen L-A, Hoebeke P, Loret N, Van Praet C, Van Laecke E, Ann R, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–7 2012/08/16. United States.CrossRef
23.
Zurück zum Zitat Haddad M, Besson R, Aubert D, Ravasse P, Lemelle J, El Ghoneimi A, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010;184:696–701.CrossRef Haddad M, Besson R, Aubert D, Ravasse P, Lemelle J, El Ghoneimi A, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010;184:696–701.CrossRef
24.
Zurück zum Zitat Mason MD, Stephany HA, Casella DP, Clayton DB, Tanaka ST, Thomas JC, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol ®j.juro. 2016;195:1239–44.CrossRef Mason MD, Stephany HA, Casella DP, Clayton DB, Tanaka ST, Thomas JC, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol ®j.juro. 2016;195:1239–44.CrossRef
25.
Zurück zum Zitat Stephany HA, Juliano TM, Clayton DB, Tanaka ST, Thomas JC, Adams MC, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190:1516–22.CrossRef Stephany HA, Juliano TM, Clayton DB, Tanaka ST, Thomas JC, Adams MC, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190:1516–22.CrossRef
26.
Zurück zum Zitat Rensing AJ, Szymanski KM, Dunn S, King S, Cain MP, Whittam BM. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis. J Pediatr Urol. 2019;15:39.e1-39.e6 Elsevier.CrossRef Rensing AJ, Szymanski KM, Dunn S, King S, Cain MP, Whittam BM. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis. J Pediatr Urol. 2019;15:39.e1-39.e6 Elsevier.CrossRef
27.
Zurück zum Zitat Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021;153:345–50 Elsevier.CrossRef Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021;153:345–50 Elsevier.CrossRef
28.
Zurück zum Zitat Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. World Journal of Urology 2019 37:12 [Internet]. Springer; 2019 [cited 2022 Jul 21];37:2775–83. Available from: https://link-springer-com.proxy.ulib.uits.iu.edu/article/https://doi.org/10.1007/s00345-019-02721-x Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. World Journal of Urology 2019 37:12 [Internet]. Springer; 2019 [cited 2022 Jul 21];37:2775–83. Available from: https://​link-springer-com.​proxy.​ulib.​uits.​iu.​edu/​article/​https://​doi.​org/​10.​1007/​s00345-019-02721-x
29.
Zurück zum Zitat Fuchs ME, Lu PL, Vyrostek SJ, Teich S, Alpert SA. Factors predicting complications after sacral neuromodulation in children. Urology Elsevier. 2017;107:214–7.CrossRef Fuchs ME, Lu PL, Vyrostek SJ, Teich S, Alpert SA. Factors predicting complications after sacral neuromodulation in children. Urology Elsevier. 2017;107:214–7.CrossRef
Metadaten
Titel
Pediatric Overactive Bladder and the Role of Sacral Neuromodulation
verfasst von
Ashley W. Johnston, MD
Benjamin M. Whittam, MD, MS
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Current Treatment Options in Pediatrics / Ausgabe 4/2022
Elektronische ISSN: 2198-6088
DOI
https://doi.org/10.1007/s40746-022-00256-9

Weitere Artikel der Ausgabe 4/2022

Poor Weight Gain

  • Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)

Cardiac Arrest in Pediatric Cardiac ICUs: Prevention Comes First

  • Cardiology/CT Surgery (K Gist, Section Editor)

Optimization of Pediatric Antibiotic Dosing Through Therapeutic Drug Monitoring

  • Pediatric Infectious Disease (M Mitchell and F Zhu, Section Editors)

Perinatal Cytomegalovirus Infection

  • Pediatric Neonatology (T Thorkelsson, Section Editor)

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Pädiatrie

Weniger Bargeld, weniger Erstickungsnotfälle?

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Pneumonie ausschließen: Auf das Röntgenbild ist offenbar Verlass

Das Thoraxröntgen ist gemäß Daten aus den USA eine zuverlässige Methode, um bei Kindern in der Notaufnahme rasch eine Lungenentzündung auszuschließen. Zur Vorsicht rät das Ärzteteam jedoch bei bestimmten klinischen Symptomen.

Kawasaki-Syndrom: Kein ASS mehr in der Akutphase?

Um Kinder mit Kawasaki-Syndrom vor entzündlich bedingten Veränderungen der Koronarien zu bewahren, werden sie in der Akutphase mit intravenösen Immunglobulinen und hochdosierter Acetylsalicylsäure (ASS) behandelt. Neuesten Daten zufolge könnte womöglich auf ASS verzichtet werden.

Neurologische Entwicklung von Kindern: Welchen Einfluss hat Stillen?

Stillen bringt zahlreiche gesundheitliche Vorteile mit sich. Ob dazu auch ein niedrigeres Risiko für Entwicklungsverzögerungen und -störungen gehört, hat nun eine israelische Studie untersucht.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.